Indication
Pustular psoriasis
Pustular psoriasis is a rare, severe variant of psoriasis characterized by the eruption of sterile, macroscopic pustules on an erythematous, inflamed base. Read more about Pustular psoriasis
3 drugs 3 manufacturers
Drugs that treat it
Common Pustular psoriasis therapies.
SPEVIGO (spesolimab-sbzo)
SPEVIGO (spesolimab-sbzo)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPustular psoriasis is a rare, severe variant of psoriasis characterized by the eruption of sterile, macroscopic pustules on an erythematous, inflamed base.
Primarily affecting the integumentary system, it can present in localized patterns, such as on the palms and soles, or as a generalized eruption that can cause life-threatening systemic inflammation, fever, and metabolic disturbances.
Pathophysiologically, the condition is driven by intense neutrophilic infiltration into the epidermis, predominantly mediated by innate immune dysregulation along the interleukin-36 signaling pathway.
- nih.gov
Pustular psoriasis is a rare, severe variant of psoriasis characterized by the eruption of sterile, macroscopic pustules on an erythematous, inflamed base Primarily affecting the integumentary system, it can present in localized patterns, such as on the palms and soles, or as a generalized eruption that can cause life-threatening systemic inflammation, fever, and metabolic disturbances
- medlineplus.gov
Primarily affecting the integumentary system, it can present in localized patterns, such as on the palms and soles, or as a generalized eruption that can cause life-threatening systemic inflammation, fever, and metabolic disturbances
- aad.org
Primarily affecting the integumentary system, it can present in localized patterns, such as on the palms and soles, or as a generalized eruption that can cause life-threatening systemic inflammation, fever, and metabolic disturbances
- nih.gov
Pathophysiologically, the condition is driven by intense neutrophilic infiltration into the epidermis, predominantly mediated by innate immune dysregulation along the interleukin-36 signaling pathway
- nih.gov
Pathophysiologically, the condition is driven by intense neutrophilic infiltration into the epidermis, predominantly mediated by innate immune dysregulation along the interleukin-36 signaling pathway
Personalize your experience
Follow Pustular psoriasis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.